Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00959374 · ClinicalTrials.gov registry record · NA

Evaluation of Dermal Closure With an Absorbable Barbed Suture as Compared to a Conventional Absorbable Suture

A NA study, sponsored by Medtronic - MITG.

Completed
Registry status
NA
Development phase
229
Enrollment target

NCT00959374 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 229 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00959374, a NA study, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
NA
Development phase
229 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the use of an absorbable barbed suture as compared to a conventional absorbable suture when used for dermal closure during certain body contouring procedures.

Interventions

  • DEVICE V-Loc 180/90 Wound Closure Device
  • DEVICE 3-0 Monocryl Absorbable Sutures

Trial Details

FieldValue
Enrollment Target 229 participants
Start Date 2009-08
Est. Completion 2012-02
Phase NA

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT00959374

The ClinicalTrials.gov registry entry for NCT00959374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which V-Loc 180/90 Wound Closure Device is the first listed.

NCT00959374 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00959374 about?

NCT00959374 is a clinical study titled "Evaluation of Dermal Closure With an Absorbable Barbed Suture as Compared to a Conventional Absorbable Suture". The objective of this study is to evaluate the use of an absorbable barbed suture as compared to a conventional absorbable suture when used for dermal closure during certain body contouring procedures.

What is the current status of trial NCT00959374?

This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2009-08. Estimated completion is 2012-02.

What interventions are being tested in trial NCT00959374?

The interventions under investigation include: V-Loc 180/90 Wound Closure Device (DEVICE), 3-0 Monocryl Absorbable Sutures (DEVICE).

Who is sponsoring clinical trial NCT00959374?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.